Rxsight Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Happy to introduce our next presentation, company is RxSight, I'm going to bring up CEO, Ron Kurtz, and then we'll do some Q&A. Ron?
Thank you very much, Robbie, and thank you for having us at the conference. These are forward-looking statements.
RxSight is focused on growing the premium cataract surgery market, which is the most profitable segment of the highest volume surgical procedure in ophthalmology. Our strategy is based on delivering both better medicine for patients and better business results for doctors and practices, an approach that our team has used previously to build high-margin premium pay businesses in ophthalmology over the past 20 years. As we will discuss, RxSight's first-in-class light adjustable lens or LAL, delivers unparalleled visual results for patients and drives growth of premium pay procedures that are critical to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
